Navigation Links
Orange corn holds promise for reducing blindness, child death

WEST LAFAYETTE, Ind. - Decreasing or increasing the function of a newly discovered gene in corn may increase vitamin A content and have significant implications for reducing childhood blindness and mortality rates, according to a Purdue University-led study.

Torbert Rocheford, the Patterson Endowed Chair of Translational Genomics and professor of agronomy at Purdue, led the study that made findings in yellow and particularly orange corn, a type he said likely originated in the Caribbean and is popular in some Asian and South American countries as well as in northern Italy. The orange color comes from relatively higher levels of carotenoids, one of which is beta-carotene. Humans convert beta-carotene, which also is abundant in carrots, into vitamin A during digestion.

Rocheford is using simple visual selection for darker orange color combined with more advanced molecular natural diversity screening techniques to create better lines of the orange corn.

"We're sort of turbocharging corn with desirable natural variation to make it darker and more nutritious," Rocheford said.

Between 250,000 and 500,000 children mostly in Africa and Southeast Asia - go blind each year because of vitamin A deficiency, according to the World Health Organization. Half of those children will die within a year of going blind. Rocheford said increasing beta-carotene levels in cereal grains, such as corn, is an economical approach to addressing these deficiencies in developing countries.

Rocheford said the gene beta-carotene hydroxylase 1 (crtR-B1) alters beta-carotene in corn in a way that reduces pro-vitamin A activity. Through a process known as hydroxylation, beta-carotene is converted into other carotenoids that can cut the amount of pro-vitamin A that is created through digestion in half, or eliminate it altogether. Reducing the function of the crtR-B1 gene would reduce hydroxylation considerably.

"Because of this, selecting a form of the gene that does not have much activity causes beta-carotene to build up," said Rocheford, whose findings were published in the journal Nature Genetics. "We're have started to move the favorable 'weak' allele into breeding materials."

Conversely, "strong alleles" increasing crtR-B1 function boost the hydroxylation process, which creates more zeaxanthin. Zeaxanthin is a micronutrient that could protect against macular degeneration, the leading cause of blindness in people over 55 in Western industrialized nations, according to the American Macular Degeneration Foundation.

Zeaxanthin makes up 75 percent of the central macula in human eyes, according to the AMDF, and data show that macular pigment increases through dietary supplements.

Rocheford said the findings are encouraging for addressing problems in both developed and developing nations.

"It's like a designer gene. We can select one version for the U.S. population to increase zeaxanthin and a different version to increase beta-carotene for the needs of the developing world," he said.

Rocheford's research will continue to look for ways to improve the nutrient profile of orange corn through simple visual selection and more advanced DNA and compound analyses. He said further efforts would focus on other genes that also hold promise to increase pro-vitamin A in corn.

Another challenge, he admits, would be introducing a new variety of corn to consumers.

"The U.S. only grows yellow and white corn, and Africa largely grows white corn," Rocheford said. "But parts of the world some parts of Asia and South America actually prefer orange corn."

Rocheford recently returned from a meeting in Zambia and saw an initial indication of consumer acceptance of orange corn there. He also stopped in northern Italy where orange corn is used for polenta, a sign that acceptance is possible in the developed world as well.


Contact: Brian Wallheimer
Purdue University

Related biology news :

1. Introducing Orange Bulldog
2. Bitter orange SRMs: Tools for product analysis/quality
3. Exposure to Agent Orange linked to prostate cancer in Vietnam veterans
4. Carnegie Mellon developing automated systems to enable precision farming of apples, oranges
5. Agent Orange exposure increases veterans risk of aggressive recurrence of prostate cancer
6. Orange peels, newspapers may lead to cheaper, cleaner ethanol fuel
7. Chlamy genome holds clues for renewable energy, the environment and human health
8. Stanfords nanowire battery holds 10 times the charge of existing ones
9. Material Technologies Holds First Electrochemical Fatigue Sensor Training for Private Inspection Firms
10. Craniosynostosis minimally invasive surgery holds more promise than old procedure
11. Cow stomach holds key to turning corn into biofuel
Post Your Comments:
Related Image:
Orange corn holds promise for reducing blindness, child death
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second time ... US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, D.C. ... US2020. , US2020’s mission is to change the trajectory of STEM education in ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology: